Announcement on Preliminary Earnings Estimate for 2025
Filed with SSE · · 4 pages · Chinese
Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix
Earlier from Dizal (Jiangsu) Pharmaceutical
- Announcement on Listing and Circulation of Shares from the 2nd Exercise Window of the 2nd Exercise Period under the 2020 Employee Stock Option Plan
- Announcement on the Results of the Partial Vesting of the 2nd Vesting Period for the Second Category of Incentive Recipients under the Initial Grant, Partial Vesting of the 1st Vesting Period for the Reserved Grant Objects under the 2022 Restricted Stock Incentive Plan, and Stock Listing
- Announcement on Changing English Name of the Company, Amending the "Articles of Association", and Handling Industrial and Commercial Change Registration
- Announcement on the Results of the First Partial Vesting of the 3rd Vesting Period for the First Category of Incentive Objects under the 2022 Restricted Stock Incentive Plan, Partial Vesting of the 2nd Vesting Period for the Second Category of Incentive Recipients under the Initial Grant, Partial Vesting of the 1st Vesting Period for the Reserved Grant Objects, and Stock Listing
- Announcement on Expected Loss in Performance for 2025
Later from Dizal (Jiangsu) Pharmaceutical
- Announcement on Early Return of Idle Raised Funds for Temporary Supplementary Working Capital
- Announcement on Voluntary Disclosure of Positive Top-line Results from the International Multicenter Phase III Clinical Trial of Shuvozhe Monotherapy as First-line Treatment for EGFR exon20ins Non-small Cell Lung Cancer
- Announcement on Voluntary Disclosure of the Latest Data of Suvozertinib as First-Line Treatment for EGFR PACC or Other Rare Mutant Non-Small Cell Lung Cancer Released at the 2026 European Lung Cancer Conference (ELCC)
- 2025 Annual Report
- Announcement on the 2nd Vesting Results in the 3rd Vesting Period for Category I Incentive Objects of Those Initially Granted in the 2022 Restricted Stock Incentive Plan and Stock Listing
Follow Dizal (Jiangsu) Pharmaceutical into a list and get an email when it puts out news.
Follow Dizal (Jiangsu) Pharmaceutical